Abstract
The widespread screening by measurement of serum prostatic specific antigen (PSA) and needle core biopsy allows more and more organ-confined prostate cancer being diagnosed. Orchiectomy as a treatment for prostate cancer almost completely disappears due to the availability of effective androgen ablative therapy. It is rarely necessary for the urologists to rely on intraoperative FS diagnosis for surgical treatment. However, there are still situations that FS is indicated for guidance of the surgical intervention as listed below: 1. Evaluation of surgical margin status during radical prostatectomy. 2. Evaluation of metastatic status of pelvic lymph nodes during radical prostatectomy. 3. Intraoperative diagnosis of adenocarcinoma in prostate from organ donors. 4. Intraoperative diagnosis of prostatic transurethral resection specimens, or simple prostatectomy specimens for nodular hyperplasia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bernie JE, Albers L, Baird S, Parsons CL. Synchronous ipsilateral renal adenocarcinoma, transitional cell carcinoma of the renal pelvis and metastatic renal lymphoma. J Urol. 2000;164:773–774.
Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol. 1988;19:1072–1079.
Fromont G, Baumert H, Cathelineau X, Rozet F, Validire P, Vallancien G. Intraoperative frozen section analysis during nerve sparing laparoscopic radical prostatectomy: feasibility study. J Urol. 2003;170:1843–1846.
Fasolis G, Degiuli P, Lancia M, et al. Periprostatic tissues intraoperative frozen section during retrograde radical retropubic prostatectomy. Arch Ital Urol Androl. 2006;78:107–111.
Goharderakhshan RZ, Sudilovsky D, Carroll LA, Grossfeld GD, Marn R, Carroll PR. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. Urology. 2002;59:709–714.
Dillenburg W, Poulakis V, Witzsch U, et al. Laparoscopic radical prostatectomy: the value of intraoperative frozen sections. Eur Urol. 2005;48:614–621.
Kausik SJ, Blute ML, Sebo TJ, et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 2002;95:1215–1219.
Shah O, Melamed J, Lepor H. Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol. 2001;165:1943–1948.
Lepor H, Kaci L. Role of intraoperative biopsies during radical retropubic prostatectomy. Urology. 2004;63:499–502.
Nazeer T, Kee KH, Ro JY, et al. Intraprostatic adipose tissue: a study of 427 whole mount radical prostatectomy specimens. Hum Pathol. 2009; 40:538–541.
Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ. The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Sur Pathol. 1989;13:21–27.
Billis A. Intraprostatic fat: does it exist? Hum Pathol. 2004;35:525.
Chuang AY, Epstein JI. Positive surgical margins in areas of capsular incision in otherwise organ-confined disease at radical prostatectomy: histologic features and pitfalls. Am J Sur Pathol. 2008;32:1201–1206.
Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277:1445–1451.
Kakehi Y, Kamoto T, Okuno H, Terai A, Terachi T, Ogawa O. Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era. Int J Urol. 2000;7:281–286.
Beissner RS, Stricker JB, Speights VO, Coffield KS, Spiekerman AM, Riggs M. Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis. Urology. 2002;59:721–725.
Epstein JI. Pathologic assessment of the surgical specimen. Urol Clin North Am. 2001;28:567–594.
Epstein JI, Oesterling JE, Eggleston JC, Walsh PC. Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J Urol. 1986;136:1234–1237.
Davis GL. Sensitivity of frozen section examination of pelvic lymph nodes for metastatic prostate carcinoma. Cancer. 1995;76:661–668.
Schned AR, Gormley EA. Florid xanthomatous pelvic lymph node reaction to metastatic prostatic adenocarcinoma. A sequela of preoperative androgen deprivation therapy. Arch Pathol Lab Med. 1996;120:96–100.
Wilcox GE, Conway EJ, Wheeler TM, Truong LD. Benign glandular inclusions detected in pelvic lymph nodes removed during staging of prostate adenocarcinoma. Mod Pathol. 1998;11:99A.
Gazdar AF. Tumors arising after organ transplantation. Sorting out their origins. JAMA. 1997;277:154–155.
Mikuz G, Montironi R, Lopez-Beltran A, Bussolati G. The dilemma of multiorgan donors with high serum PSA – a pathologist’s proposal. Virchows Arch. 2006;449:273–276.
Algaba F, Arce Y, Lopez-Beltran A, Montironi R, Mikuz G, Bono AV. Intraoperative frozen section diagnosis in urological oncology. Eur Urol. 2005;47:129–136.
Geddy PM, Reid IN. Selective sampling of yellow prostate chips: a specific method for detecting prostatic adenocarcinoma. Urol Int. 1996;56:33–35.
Algaba F, Epstein JI, Aldape HC, et al. Assessment of prostate carcinoma in core needle biopsy – definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer. 1996;78:376–381.
Ro JY, Amin MB, Kim KR, Ayala AG. Tumors and tumorous conditions of the the male genital tract. In: M. FCD, ed. Diagnostic Histopathology of Tumors. 3rd ed. London: Churchill Livingstone; 2007:749–879.
Molinie V, Fromont G, Sibony M, et al. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol. 2004;17:1180–1190.
Helpap B. Small suggestive lesions of the prostate. Histological and immunohistochemical analyses – report of the uropathology consultation service. Pathologe. 2005;26:398–404.
Bonkhoff H, Remberger K. Benign microglandular prostate lesions. Diagnostic criteria na differential diagnosis. Pathologe. 1998;19:1–11.
Algaba F, Trias I. Diagnostic limits in precursor lesions of prostatic cancer. Eur Urol. 1996;30:212–221.
Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17:328–348.
Grignon DJ, Ro JY, Srigley JR, Troncoso P, Raymond AK, Ayala AG. Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation. Am J Sur Pathol. 1992;16:383–391.
Bostwick DG, Chang L. Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol. 1999;17:199–205.
Epstein JI, Walsh PC, Sanfilippo F. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Sur Pathol. 1996;20:851–857.
Thorson P, Swanson PE, Vollmer RT, Humphrey PA. Basal cell hyperplasia in the peripheral zone of the prostate. Mod Pathol. 2003;16:598–606.
Kaleem Z, Swanson PE, Vollmer RT, Humphrey PA. Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens. Am J Clin Pathol. 1998;109:695–703.
Di Silverio F, Monti S, Sciarra A, et al. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate. 1998;37:77–83.
Malpica A, Ro JY, Troncoso P, Ordonez NG, Amin MB, Ayala AG. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994;25:390–395.
Rahemtullah A, Oliva E. Nephrogenic adenoma: an update on an innocuous but troublesome entity. Adv Anat Pathol. 2006;13:247–255.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Algaba, F., Shen, S.S., Truong, L.D., Ro, J.Y. (2009). Prostate. In: Frozen Section Library: Genitourinary Tract. Frozen Section Library, vol 2. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0691-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0691-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0690-8
Online ISBN: 978-1-4419-0691-5
eBook Packages: MedicineMedicine (R0)